|
|
Name: |
SILVERARC CAPITAL MANAGEMENT LLC |
City: |
BOSTON |
State: |
MA |
Zip: |
02116 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
79 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
VRNA |
Verona Pharma Plc |
1 |
- |
$0.00 |
$34,657,000 |
545,872 |
7.24% |
10,693,000 |
29,858 |
0.677 |
N/A |
|
MRUS |
Merus Nv |
2 |
- |
$52.60 |
$34,136,000 |
811,021 |
7.13% |
5,506,000 |
130,176 |
1.132 |
N/A |
|
NUVL |
Nuvalent, Inc. |
3 |
- |
$0.00 |
$31,135,000 |
439,018 |
6.5% |
-178,000 |
39,004 |
0.627 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
4 |
- |
$0.00 |
$29,145,000 |
719,992 |
6.09% |
8,570,000 |
-19,571 |
0.955 |
N/A |
|
INSM |
Insmed Inc |
5 |
- |
$100.64 |
$24,517,000 |
321,366 |
5.12% |
-1,182,000 |
-50,864 |
0.169 |
Biotechnology |
|
KALV |
Kalvista Pharmaceuticals Inc |
6 |
- |
$11.31 |
$19,606,000 |
1,698,984 |
4.1% |
14,421,000 |
1,086,811 |
3.243 |
N/A |
|
VCYT |
Veracyte, Inc. |
7 |
- |
$27.03 |
$18,793,000 |
633,832 |
3.93% |
-1,137,000 |
130,551 |
0.765 |
Biotechnology |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
8 |
- |
$63.19 |
$17,883,000 |
337,605 |
3.74% |
2,550,000 |
63,709 |
0.476 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
9 |
- |
$9.37 |
$16,084,000 |
1,309,224 |
3.36% |
-182,000 |
78,824 |
1.393 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
10 |
- |
$13.70 |
$15,276,000 |
1,381,158 |
3.19% |
3,343,000 |
260,685 |
3.28 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
11 |
- |
$28.40 |
$12,142,000 |
411,312 |
2.54% |
-3,667,000 |
-132,339 |
0.305 |
N/A |
|
SLNO |
Soleno Therapeutics Inc |
12 |
New |
$0.16 |
$11,890,000 |
166,417 |
2.48% |
11,890,000 |
166,417 |
0.209 |
N/A |
|
ASND |
Ascendis Pharma AS |
13 |
- |
$172.60 |
$11,807,000 |
75,751 |
2.47% |
4,718,000 |
24,260 |
0.117 |
N/A |
|
IRON |
Disc Medicine, Inc |
14 |
- |
$52.96 |
$11,738,000 |
236,471 |
2.45% |
4,740,000 |
126,090 |
0.795 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
15 |
- |
$0.00 |
$11,496,000 |
2,060,240 |
2.4% |
1,987,000 |
881,940 |
2.921 |
N/A |
|
ETNB |
89bio, Inc. |
16 |
- |
$9.82 |
$10,981,000 |
1,510,498 |
2.29% |
10,226,000 |
1,413,987 |
1.426 |
N/A |
|
ERAS |
Erasca, Inc. |
17 |
- |
$1.27 |
$10,094,000 |
7,367,996 |
2.11% |
-8,841,000 |
-175,905 |
2.609 |
N/A |
|
WVE |
Wave Life Sciences Ltd. |
18 |
- |
$6.50 |
$8,487,000 |
1,050,374 |
1.77% |
955,000 |
441,477 |
0.882 |
N/A |
|
NBIX |
Neurocrine Biosciences Inc |
19 |
New |
$125.69 |
$8,028,000 |
72,583 |
1.68% |
8,028,000 |
72,583 |
0.078 |
Biotechnology |
|
TVTX |
Travere Therapeutics, Inc |
20 |
- |
$14.80 |
$7,327,000 |
408,849 |
1.53% |
2,495,000 |
131,484 |
0.456 |
N/A |
|
GOSS |
Gossamer Bio Inc |
21 |
- |
$1.23 |
$6,953,000 |
6,320,684 |
1.45% |
1,370,000 |
148,837 |
2.804 |
N/A |
|
GILD |
Gilead Sciences Inc |
22 |
- |
$110.87 |
$6,950,000 |
62,029 |
1.45% |
6,026,000 |
52,029 |
0.005 |
Biotechnology |
|
HLXB |
Helix Acquisition Corp. Ii |
23 |
- |
$10.62 |
$6,931,000 |
613,393 |
1.45% |
1,541,000 |
100,024 |
3.334 |
N/A |
|
AZYO |
Aziyo Biologics, Inc. |
24 |
- |
$0.00 |
$6,755,000 |
2,670,056 |
1.41% |
89,000 |
887,785 |
7.839 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
25 |
- |
$0.00 |
$6,289,000 |
166,074 |
1.31% |
708,000 |
93,558 |
0.317 |
N/A |
|
MLYS |
Mineralys Therapeutics, Inc. |
26 |
New |
$0.00 |
$5,373,000 |
338,354 |
1.12% |
5,373,000 |
338,354 |
0.68 |
N/A |
|
CGEN |
Compugen Ltd (USA) |
27 |
- |
$1.78 |
$4,227,000 |
2,895,430 |
0.88% |
1,742,000 |
1,271,053 |
3.494 |
Biotechnology |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
28 |
- |
$0.00 |
$4,178,000 |
81,331 |
0.87% |
526,000 |
15,376 |
0.184 |
N/A |
|
ALKS |
Alkermes Plc |
29 |
New |
$28.61 |
$4,123,000 |
124,871 |
0.86% |
4,123,000 |
124,871 |
0.068 |
Drug Delivery |
|
OCUL |
Ocular Therapeutix, Inc |
30 |
New |
$0.00 |
$4,043,000 |
551,570 |
0.84% |
4,043,000 |
551,570 |
0.354 |
N/A |
|
KURA |
Kura Oncology Inc |
32 |
New |
$5.77 |
$3,837,000 |
581,369 |
0.8% |
3,837,000 |
581,369 |
0 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
31 |
New |
$43.18 |
$3,837,000 |
111,000 |
0.8% |
3,837,000 |
111,000 |
0.758 |
N/A |
|
CLDX |
Celldex Therapeutics Inc |
33 |
- |
$20.35 |
$3,738,000 |
205,962 |
0.78% |
-2,947,000 |
-58,598 |
0.279 |
Diagnostic Substances |
|
DNTH |
Dianthus Therapeutics Ord Shs |
34 |
New |
$0.70 |
$3,453,000 |
190,334 |
0.72% |
3,453,000 |
190,334 |
0.586 |
N/A |
|
MDGL |
Madrigal Pharmaceuticals Inc |
35 |
New |
$302.64 |
$3,426,000 |
10,344 |
0.72% |
3,426,000 |
10,344 |
0.04 |
Diagnostic Substances |
|
CERS |
Cerus Corp |
36 |
- |
$1.41 |
$3,415,000 |
2,456,537 |
0.71% |
971,000 |
869,309 |
1.47 |
Biotechnology |
|
TELA |
Tela Bio, Inc. |
37 |
- |
$1.94 |
$3,381,000 |
2,771,288 |
0.71% |
-5,877,000 |
-294,361 |
11.316 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
38 |
- |
$0.00 |
$3,347,000 |
232,758 |
0.7% |
-6,685,000 |
-366,194 |
0.178 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
39 |
- |
$0.00 |
$3,334,000 |
530,000 |
0.7% |
309,000 |
-204,234 |
0.521 |
N/A |
|
BPMC |
Blueprint Medicines Corp |
40 |
New |
$128.18 |
$3,305,000 |
37,345 |
0.69% |
3,305,000 |
37,345 |
0.057 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
41 |
- |
$20.74 |
$3,255,000 |
188,069 |
0.68% |
-878,000 |
35,674 |
0.299 |
N/A |
|
BNTC |
Benitec Biopharma Ltd |
42 |
New |
$0.20 |
$3,253,000 |
250,000 |
0.68% |
3,253,000 |
250,000 |
0.893 |
N/A |
|
LQDA |
Liquidia Technologies Inc |
43 |
New |
$12.46 |
$3,157,000 |
214,057 |
0.66% |
3,157,000 |
214,057 |
0.279 |
N/A |
|
PTCT |
PTC Therapeutics, Inc. |
44 |
New |
$48.84 |
$3,077,000 |
60,389 |
0.64% |
3,077,000 |
60,389 |
0.067 |
Biotechnology |
|
MTSR |
Metsera, Inc. |
45 |
New |
$28.45 |
$3,069,000 |
112,759 |
0.64% |
3,069,000 |
112,759 |
0.107 |
N/A |
|
BDSX |
Biodesix Inc |
46 |
- |
$0.00 |
$2,562,000 |
4,098,406 |
0.54% |
-4,066,000 |
-233,875 |
2.823 |
N/A |
|
DCTH |
Delcath Systems Inc |
47 |
- |
$13.60 |
$2,437,000 |
191,470 |
0.51% |
567,000 |
36,145 |
1.253 |
Research Services |
|
QURE |
uniQure B.V. |
48 |
- |
$13.94 |
$2,156,000 |
203,400 |
0.45% |
390,000 |
103,400 |
0.457 |
N/A |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
49 |
New |
$27.67 |
$1,959,000 |
88,215 |
0.41% |
1,959,000 |
88,215 |
0.218 |
N/A |
|
SLDB |
Solid Biosciences Inc |
50 |
- |
$4.87 |
$1,673,000 |
452,239 |
0.35% |
1,673,000 |
452,239 |
1.172 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
51 |
New |
$0.00 |
$1,662,000 |
874,869 |
0.35% |
1,662,000 |
874,869 |
0.633 |
N/A |
|
CCCC |
C4 Therapeutics, Inc. |
52 |
- |
$0.00 |
$1,412,000 |
882,300 |
0.3% |
-2,984,000 |
-338,831 |
1.272 |
N/A |
|
KALA |
Kala Pharmaceuticals, Inc. |
53 |
- |
$4.76 |
$1,410,000 |
246,079 |
0.29% |
-194,000 |
15,009 |
5.338 |
N/A |
|
UNCY |
Unicycive Therapeutics, Inc. |
54 |
- |
$0.00 |
$1,388,000 |
2,413,489 |
0.29% |
-587,000 |
-73,220 |
2.558 |
N/A |
|
ABVX |
Abivax S.A |
55 |
- |
$7.65 |
$1,318,000 |
210,901 |
0.28% |
-769,000 |
-74,219 |
0.34 |
N/A |
|
KOD |
Kodiak Sciences Inc. |
56 |
- |
$3.73 |
$1,239,000 |
441,807 |
0.26% |
-8,711,000 |
-558,193 |
0.986 |
N/A |
|
SION |
Sionna Therapeutics, Inc. |
57 |
New |
$0.00 |
$1,194,000 |
114,138 |
0.25% |
1,194,000 |
114,138 |
0.259 |
N/A |
|
IFRX |
InflaRx NV |
58 |
New |
$0.79 |
$1,185,000 |
1,161,567 |
0.25% |
1,185,000 |
1,161,567 |
4.962 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
59 |
- |
$0.30 |
$1,063,000 |
3,088,505 |
0.22% |
1,063,000 |
3,088,505 |
2.561 |
N/A |
|
MODD |
Modular Medical, Inc |
60 |
- |
$0.75 |
$1,045,000 |
958,881 |
0.22% |
-698,000 |
-313,134 |
2.74 |
N/A |
|
AARD |
Aardvark Therapeutics, Inc. |
61 |
New |
$0.00 |
$897,000 |
119,496 |
0.19% |
897,000 |
119,496 |
0.551 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
62 |
New |
$0.00 |
$340,000 |
10,121 |
0.07% |
340,000 |
10,121 |
0.013 |
N/A |
|
AVDL |
AVADEL Pharmaceuticals Plc |
63 |
New |
$15.99 |
$308,000 |
39,366 |
0.06% |
308,000 |
39,366 |
0.041 |
Drug Delivery |
|
GUTS |
Fractyl Health, Inc. |
64 |
- |
$1.62 |
$283,000 |
237,448 |
0.06% |
-81,000 |
60,526 |
0.496 |
N/A |
|
VXRT |
Vaxart Inc |
65 |
- |
$0.45 |
$278,000 |
683,825 |
0.06% |
-436,000 |
-393,957 |
0.625 |
Biotechnology |
|
COGT |
Cogent Biosciences, Inc. |
77 |
Closed |
$7.18 |
$0 |
0 |
0% |
-7,185,000 |
-921,137 |
0 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
70 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,360,000 |
-233,281 |
0 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
76 |
Closed |
$36.36 |
$0 |
0 |
0% |
-5,233,000 |
-124,388 |
0 |
Restaurants |
|
BIOA |
Bioage Labs, Inc. |
69 |
Closed |
$4.13 |
$0 |
0 |
0% |
-231,000 |
-39,974 |
0 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
75 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,339,000 |
-40,788 |
0 |
N/A |
|
PSTX |
Poseida Therapeutics, Inc. |
68 |
Closed |
$9.50 |
$0 |
0 |
0% |
-9,718,000 |
-1,012,307 |
0 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
74 |
Closed |
$13.98 |
$0 |
0 |
0% |
-1,917,000 |
-100,000 |
0 |
N/A |
|
ITCI |
Intra Cellular Therapies Inc |
67 |
Closed |
$131.87 |
$0 |
0 |
0% |
-14,957,000 |
-179,085 |
0 |
N/A |
|
KPTI |
Karyopharm Therapeutics Inc. |
73 |
Closed |
$4.31 |
$0 |
0 |
0% |
-403,000 |
-595,990 |
0 |
N/A |
|
GERN |
Geron Corporation |
79 |
Closed |
$1.41 |
$0 |
0 |
0% |
-3,257,000 |
-920,022 |
0 |
Drug Manufacturers - ... |
|
INCY |
Incyte Corp |
66 |
Closed |
$68.10 |
$0 |
0 |
0% |
-3,384,000 |
-49,000 |
0 |
Biotechnology |
|
PLRX |
Pliant Therapeutics, Inc. |
72 |
Closed |
$0.00 |
$0 |
0 |
0% |
-17,326,000 |
-1,315,601 |
0 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
78 |
Closed |
$0.44 |
$0 |
0 |
0% |
-903,000 |
-121,274 |
0 |
Biotechnology |
|
SRRK |
Scholar Rock Holding Corp |
71 |
Closed |
$35.42 |
$0 |
0 |
0% |
-7,920,000 |
-183,243 |
0 |
N/A |
|